Menyhart O - Search Results

1

MultipleTesting.com: A tool for life science researchers for multiple hypothesis testing correction.

Menyhart O, Weltz B, Győrffy B. Menyhart O, et al. PLoS One. 2021 Jun 9;16(6):e0245824. doi: 10.1371/journal.pone.0245824. eCollection 2021. PLoS One. 2021. PMID: 34106935 Free PMC article.

2

Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches.

Menyhárt O, Győrffy B. Menyhárt O, et al. Cancer Metastasis Rev. 2020 Mar;39(1):211-233. doi: 10.1007/s10555-020-09854-1. Cancer Metastasis Rev. 2020. PMID: 31970590 Free PMC article. Review.

3

Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis.

Menyhárt O, Győrffy B. Menyhárt O, et al. Comput Struct Biotechnol J. 2021 Jan 22;19:949-960. doi: 10.1016/j.csbj.2021.01.009. eCollection 2021. Comput Struct Biotechnol J. 2021. PMID: 33613862 Free PMC article. Review.

4

Correction: MultipleTesting.com: A tool for life science researchers for multiple hypothesis testing correction.

Menyhart O, Weltz B, Győrffy B. Menyhart O, et al. PLoS One. 2022 Sep 9;17(9):e0274662. doi: 10.1371/journal.pone.0274662. eCollection 2022. PLoS One. 2022. PMID: 36084071 Free PMC article.

5

Author Correction: Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets.

Nagy Á, Lánczky A, Menyhárt O, Győrffy B. Nagy Á, et al. Among authors: menyhart o. Sci Rep. 2018 Jul 26;8(1):11515. doi: 10.1038/s41598-018-29514-3. Sci Rep. 2018. PMID: 30046141 Free PMC article.

6

Demographic shift disproportionately increases cancer burden in an aging nation: current and expected incidence and mortality in Hungary up to 2030.

Menyhárt O, Fekete JT, Győrffy B. Menyhárt O, et al. Clin Epidemiol. 2018 Aug 29;10:1093-1108. doi: 10.2147/CLEP.S155063. eCollection 2018. Clin Epidemiol. 2018. PMID: 30214314 Free PMC article.

7

Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma.

Menyhárt O, Nagy Á, Győrffy B. Menyhárt O, et al. R Soc Open Sci. 2018 Dec 5;5(12):181006. doi: 10.1098/rsos.181006. eCollection 2018 Dec. R Soc Open Sci. 2018. PMID: 30662724 Free PMC article.

8

Principles of tumorigenesis and emerging molecular drivers of SHH-activated medulloblastomas.

Menyhárt O, Győrffy B. Menyhárt O, et al. Ann Clin Transl Neurol. 2019 Mar 19;6(5):990-1005. doi: 10.1002/acn3.762. eCollection 2019 May. Ann Clin Transl Neurol. 2019. PMID: 31139698 Free PMC article. Review.

9

Gene Expression Indicates Altered Immune Modulation and Signaling Pathway Activation in Ovarian Cancer Patients Resistant to Topotecan.

Menyhárt O, Fekete JT, Győrffy B. Menyhárt O, et al. Int J Mol Sci. 2019 Jun 5;20(11):2750. doi: 10.3390/ijms20112750. Int J Mol Sci. 2019. PMID: 31195594 Free PMC article.

10

Gene expression-based biomarkers designating glioblastomas resistant to multiple treatment strategies.

Menyhárt O, Fekete JT, Győrffy B. Menyhárt O, et al. Carcinogenesis. 2021 Jun 21;42(6):804-813. doi: 10.1093/carcin/bgab024. Carcinogenesis. 2021. PMID: 33754151 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page